An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Treatment Acquiring Traction Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of rapid British shipping. Sellers market the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Express Concerns
However, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could lead to individuals injecting products of unknown origin.
Some experts said the popularity for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Content Removal
Based on TikTok, the service has taken down violative material and banned associated hashtags and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Investigations also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, glowing reviews and detailed guides for mixing or administering at residence.
After moments of entering one group, a seller shared WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.
Product Information and Pricing
Inside these groups, messages display black plastic packages with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has already encountered individuals harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may subject patients to possibly significant medical dangers”.
